Sign In
Buy TXG
$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript
10:31am, Saturday, 09'th May 2026
Torex Gold Resources Inc. (TXG:CA) Q1 2026 Earnings Call Transcript
10x Genomics Q1 Earnings Call Highlights
02:10am, Saturday, 09'th May 2026
10x Genomics NASDAQ: TXG reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument
10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up
11:45am, Friday, 08'th May 2026
TXG beats Q1 estimates as consumables growth, margin expansion and lower operating costs narrow losses year over year.
10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript
01:01am, Friday, 08'th May 2026
10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript
10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates
07:01pm, Thursday, 07'th May 2026
10x Genomics (TXG) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.36 per share a year ago.
10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
07:01pm, Thursday, 07'th May 2026
While the top- and bottom-line numbers for 10x Genomics (TXG) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compa
10x Genomics Reports First Quarter 2026 Financial Results
04:05pm, Thursday, 07'th May 2026
PLEASANTON, Calif., May 7, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Thursday, 30'th Apr 2026
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
04:05pm, Wednesday, 29'th Apr 2026
PLEASANTON, Calif., April 29, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i
SAN CARLOS, Calif.--(BUSINESS WIRE)--LiquidCell Dx, a precision diagnostics company building a blood-based platform for tumor microenvironment profiling, today announced the appointment of Mirna Jaros
10x Genomics Stock Up on Atera Launch, Spatial Biology Scale Enhanced
10:21am, Monday, 20'th Apr 2026
TXG stock jumps after unveiling Atera, a next-gen spatial biology platform aiming to scale single-cell analysis and deepen its role in drug discovery and research.
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
10:00pm, Saturday, 18'th Apr 2026
Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at Scale Debuts at AACR Annual Meeting 2026 with Data from Leading Research Institutions, Including the June Lab at the
Analyzing Hinge Health (NYSE:HNGE) and 10x Genomics (NASDAQ:TXG)
01:11am, Thursday, 16'th Apr 2026
Hinge Health (NYSE: HNGE - Get Free Report) and 10x Genomics (NASDAQ: TXG - Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two companies bas
10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
04:05pm, Wednesday, 15'th Apr 2026
PLEASANTON, Calif., April 15, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ended
Comparing 10x Genomics (NASDAQ:TXG) and HeartSciences (NASDAQ:HSCS)
01:58am, Friday, 10'th Apr 2026
10x Genomics (NASDAQ: TXG - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based
